| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 30.17 Billion | USD 56.40 Billion | 7.2% | 2024 |
FrequentlyAsked Questions
The global active implantable medical devices market is expected to grow due to rising prevalence of chronic diseases, technological advancements in implantable devices, an aging population, increasing demand for minimally invasive surgeries, and supportive government regulations.
According to a study, the global active implantable medical devices market size was worth around USD 30.17 Billion in 2024 and is expected to reach USD 56.40 Billion by 2034.
The global active implantable medical devices market is expected to grow at a CAGR of 7.2% during the forecast period.
North America is expected to dominate the active implantable medical devices market over the forecast period.
Leading players in the global active implantable medical devices market include Cardinal Health Inc., C. R. Bard Inc., Boston Scientific Corporation, Biotronik SE, Co. KG, Abbott Laboratories, LivaNova PLC, Johnson and Johnson, Integra LifeSciences Holdings Corporation, Globus Medical Inc., CONMED Corporation, among others.
The report explores crucial aspects of the active implantable medical devices market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients